TABLE 5.
Agreement between on-site replicate sample CD4 and CD8 countsa
CD4 stratum and laboratory | CD4 count (cells/μl)
|
CD8 count (cells/μl)
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
6 h
|
24 h
|
6 h
|
24 h
|
|||||||||
10th | 50th | 90th | 10th | 50th | 90th | 10th | 50th | 90th | 10th | 50th | 90th | |
All strata | ||||||||||||
All labs | −29 | 10b | 72 | −62 | 2 | 65 | −120 | 23* | 194 | −206 | −21* | 140 |
A | −22 | 18* | 72 | −93 | 7 | 55 | −75 | 59* | 207 | −379 | −2 | 212 |
B | −59 | −7* | 69 | −132 | −33* | 14 | −304 | −42* | 193 | −396 | −140* | 9 |
C | −10 | 9* | 66 | −41 | 2 | 111 | −52 | 39* | 257 | −169 | 4 | 234 |
D | −25 | 14* | 75 | −5 | 20* | 89 | −142 | −1 | 158 | −106 | 11 | 103 |
E | −5 | 21* | 74 | −29 | 4 | 43 | −49 | 32* | 183 | −107 | −10* | 110 |
<200 | ||||||||||||
All labs | −15 | 5* | 38 | −35 | 1 | 38 | −102 | 21* | 202 | −185 | −4* | 154 |
A | −14 | 11* | 41 | −156 | 10* | 31 | −66 | 63* | 227 | −972 | 44 | 246 |
B | −32 | −1* | 58 | −48 | −25* | 3 | −233 | −33 | 205 | −493 | −142* | −49 |
C | −6 | 0 | 23 | −20 | −1 | 54 | −20 | 39* | 208 | −159 | 20 | 208 |
D | −4 | 6* | 36 | −3 | 12* | 52 | −99 | −4 | 183 | −72 | 14 | 115 |
E | −5 | 9* | 43 | −14 | 6* | 39 | −57 | 23 | 189 | −67 | 10 | 132 |
≥200 | ||||||||||||
All labs | −50 | 24* | 105 | −92 | 6 | 101 | −155 | 25* | 182 | −223 | −38* | 124 |
A | −27 | 24* | 87 | −71 | 2 | 73 | −77 | 57* | 201 | −288 | −23 | 172 |
B | −84 | −15 | 112 | −165 | −58* | 42 | −325 | −50* | 156 | −362 | −136* | 36 |
C | −31 | 26* | 95 | −64 | 34 | 149 | −73 | 38* | 240 | −181 | −26 | 312 |
D | −90 | 36* | 100 | −21 | 51* | 132 | −358 | 15 | 108 | −158 | −10 | 89 |
E | −7 | 32* | 128 | −46 | 2 | 48 | −31 | 51* | 170 | −148 | −45* | 82 |
See Table 4, footnote a.
*, P < 0.05 for the estimated 50th percentile by the Wilcoxon signed-rank test.